Fecal microbiota transplantation has been shown to be an effective treatment for recalcitrant C. difficile infections. The Medicare Part B administrative contractor for Kentucky and Ohio has expressed potential interest in covering the procedure, according to an AAPC report.
A number of commercial payers, such as Aetna and Blue Cross Blue Shield, already cover the procedure for patients with current CDI.
More articles on coding and billing:
MTBC credit line increases to $3M
Foundation for a Healthy Kentucky calls for price transparency
Medicare spending increases with patient age
Here are five hospitals and health systems investing in their outpatient strategy, as reported by Becker’s: 1. Morgantown-based West Virginia…
Here are five surgeons in recent headlines, as reported by Becker’s: 1. Jeffrey Clark, MD, is the first and only…
Cardiologists at the University of Minnesota in Minneapolis are voicing concerns over the university’s proposed merger with Duluth, Minn.-based Essentia…
Comments are closed.